VEGFA and neoplasm: Tumor growth inhibition rate was significantly increased, confirming that UTMD combined with drug-carrying MBs could improve the anti-angiogenesis effect of Endostar by downregulating VEGF expression, thus, achieving tumor growth inhibition.